McDonald Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

McDonald Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$105K	Buy	+211	New	+$93.5K	0.03%	265
2024 Q3	–	Sell	-1,510	Closed	-$708K	–	248
2024 Q2	$708K	Hold	1,510	–	–	0.19%	134
2024 Q1	$631K	Hold	1,510	–	–	0.17%	147
2023 Q4	$614K	Hold	1,510	–	–	0.18%	140
2023 Q3	$525K	Hold	1,510	–	–	0.17%	141
2023 Q2	$531K	Hold	1,510	–	–	0.16%	150
2023 Q1	$476K	Hold	1,510	–	–	0.15%	153
2022 Q4	$436K	Hold	1,510	–	–	0.15%	149
2022 Q3	$437K	Sell	1,510 -100	-6%	-$28.8K	0.17%	149
2022 Q2	$454K	Hold	1,610	–	–	0.12%	187
2022 Q1	$420K	Buy	+1,610	New	+$382K	0.09%	219
2021 Q4	–	Sell	-1,575	Closed	-$286K	–	721
2021 Q3	$286K	Hold	1,575	–	–	0.07%	251
2021 Q2	$318K	Sell	1,575 -42	-3%	-$8.79K	0.08%	242
2021 Q1	$347K	Sell	1,617 -56	-3%	-$12.3K	0.09%	221
2020 Q4	$395K	Buy	+1,673	New	+$384K	0.11%	193

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

McDonald Partners's VRTX Position: Q2 2026 in Review

McDonald Partners opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 211 shares worth $105K. The stake represents 0.03% of the portfolio and ranks #265 among its holdings. This is a return to the name: McDonald Partners previously reported a position in VRTX as recently as Q2 2024.

McDonald Partners first reported a position in VRTX in Q4 2020 and has held it in 15 quarters since. The position peaked at $708K in Q2 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

McDonald Partners held 211 shares of Vertex Pharmaceuticals worth $105K as of Q2 2026.
Vertex Pharmaceuticals was a new McDonald Partners position in Q2 2026.
Vertex Pharmaceuticals made up 0.03% of McDonald Partners's portfolio in Q2 2026, its #265 holding.
McDonald Partners first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
McDonald Partners's Vertex Pharmaceuticals position peaked at $708K in Q2 2024.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.